Subscribe to an RSS Feed Reports:
ImClone Systems Incorporated (?211711):
Don't see the Scenario report you want?
- FDA Approval Decisions Report for Aug, 2007 The Revere FDA Approval Decision Report provides one of the most comprehensive and accurate event calendars for PDUFA dates-expected FDA approval dates for filed drugs. In particular, this report identifies Biotech/Pharmaceutical companies with expected FDA approvals in the next 3 months and reviews all FDA approval decisions in the current month. Revere - Aug 01, 2007 - PDF - View Report »
- FDA Approval Decisions Report for Mar, 2006 Comprehensive and accurate event calendars for PDUFA dates-expected FDA approval dates for filed drugs. Revere - Mar 01, 2006 - PDF - View Report »
- FDA Approval Decisions Report for Nov, 2007 The Revere FDA Approval Decision Report provides one of the most comprehensive and accurate event calendars for PDUFA dates-expected FDA approval dates for filed drugs. In particular, this report identifies Biotech/Pharmaceutical companies with expected FDA approvals in the next 3 months and reviews all FDA approval decisions in the current month. Revere - Nov 01, 2007 - PDF - View Report »
- FDA Approval Decisions Report for Oct, 2007 The Revere FDA Approval Decision Report provides one of the most comprehensive and accurate event calendars for PDUFA dates-expected FDA approval dates for filed drugs. In particular, this report identifies Biotech/Pharmaceutical companies with expected FDA approvals in the next 3 months and reviews all FDA approval decisions in the current month. Revere - Oct 01, 2007 - PDF - View Report »
- Competitors by Product for ImClone Systems Incorporated (IMCL) Exact product by product comparables to each of a company's competitors which trade on a major US exchange. Revere - Nov 22, 2008 - HTML - $75.00 - Add to Cart »
- Drug/Medical Device for ImClone Systems Incorporated (IMCL) The most complete and accurate coverage of a company's FDA approved products and pipeline candidates. Revere - Nov 22, 2008 - PDF - $70.00 - Add to Cart »
- Merger and Acquisition Scenario for APP Pharmaceuticals, Inc. (APPX) and ImClone Systems Incorporated (IMCL) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Jul 12, 2008 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for Abbott Laboratories (ABT) and ImClone Systems Incorporated (IMCL) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Nov 22, 2008 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for Acambis plc (ADR) (ACAM) and ImClone Systems Incorporated (IMCL) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Mar 11, 2006 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for Allergan, Inc. (AGN) and ImClone Systems Incorporated (IMCL) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Nov 22, 2008 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for Altana AG (ADR) (AAA) and ImClone Systems Incorporated (IMCL) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Dec 16, 2006 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for Amgen, Inc. (AMGN) and ImClone Systems Incorporated (IMCL) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Nov 22, 2008 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for Amylin Pharmaceuticals, Inc. (AMLN) and ImClone Systems Incorporated (IMCL) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Jul 26, 2008 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for AstraZeneca plc (ADR) (AZN) and ImClone Systems Incorporated (IMCL) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Nov 22, 2008 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for Barr Pharmaceuticals, Inc. (BRL) and ImClone Systems Incorporated (IMCL) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Nov 22, 2008 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for BioMarin Pharmaceutical Inc. (BMRN) and ImClone Systems Incorporated (IMCL) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Jun 14, 2008 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for Biogen Idec Inc. (BIIB) and ImClone Systems Incorporated (IMCL) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Nov 22, 2008 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for Biovail Corporation (USA) (BVF) and ImClone Systems Incorporated (IMCL) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Aug 25, 2007 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for Bristol Myers Squibb Co. (BMY) and ImClone Systems Incorporated (IMCL) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Nov 22, 2008 - HTML - $250.00 - Add to Cart »
- Merger and Acquisition Scenario for Celgene Corporation (CELG) and ImClone Systems Incorporated (IMCL) See what a hypothetical merger or acquisition between two firms would look like, with a particular focus on overlapping and complementary product lines and key business relationships. Revere - Nov 22, 2008 - HTML - $250.00 - Add to Cart »